1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SETD2 heterozygous loss in leukemia leads to chemotherapy resistance through attenuation of the DNA damage response
    Meeting Abstract

    Mar, B. G.; Kahn, J.; Zon, R. L.; Grauman, P. V.; Boettger, K.; Chu, S. H.; Armstrong, S. A.; Ebert, B. L.
    Blood (2015)

    Fulltext@MSK | Save
  • Clinical evaluation of Xpert(R) BCR-ABL Ultra, an automated and standardized cartridge-based assay for the quantification of BCR-ABL1
    Meeting Abstract

    Mauro, M. J.; Press, R. D.; Snyder, D. S.; Huang, Q.; Pinilla-Ibarz, J.; Qin, D. H.; Lockwood, C.; Payton, J. E.; Uy, G. L.; Kalaycio, M. E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Investigating effect of genetic admixture and donor/recipient genetic disparity on transplant outcomes
    Meeting Abstract

    Madbouly, A.; Wang, T.; Albrecht, M.; Paunic, V.; Haagenson, M. D.; Vierra-Green, C.; Fleischhauer, K.; Hsu, K. C.; Verneris, M. R.; Majhail, N. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • A clinical measure of DNA methylation predicts outcome in de novo AML
    Meeting Abstract

    Luskin, M. R.; Gimotty, P.; Smith, C.; Loren, A.; Figueroa, M.; Harrison, J.; Sun, Z. X.; Tallman, M. S.; Paietta, E.; Litzow, M. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Induction with bortezomib and dexamethasone (BD) followed by risk adapted high dose melphalan and autologous stem cell transplantation and BD consolidation in patients with AL amyloidosis: A phase II feasibility study
    Meeting Abstract

    Landau, H.; Montanez, N.; Cowan, A.; Hoover, E.; Flombaum, C.; Liu, J.; Maurer, M.; Lendvai, N.; Landgren, O.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Prospective evaluation of cord blood (CB) & haplo-identical donor availability reveals compromised donor access for both graft types in minorities and high rates of failure to clear haplo donors in adult patients
    Meeting Abstract

    Kosuri, S.; Wolff, T. F.; Byam, C.; Lauer, E.; Yoo, Y.; Perales, M. A.; Giralt, S. A.; Scaradavou, A.; Ponce, D. M.; Barker, J. N.
    Blood (2015)

    Fulltext@MSK | Save
  • High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse risk features and poor outcome in pediatric acute myeloid leukemia: A report from the Children's Oncology Group
    Meeting Abstract

    Laszlo, G. S.; Alonzo, T. A.; Gudgeon, C. J.; Harrington, K. H.; Kentsis, A.; Gerbing, R. B.; Wang, Y. C.; Ries, R. E.; Raimondi, S. C.; Hirsch, B. A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Ibrutinib alone and in combination with dexamethasone and carfilzomib significantly inhibits cell proliferation in primary mediastinal B-cell lymphoma (PMBL): Ibrutinib may be a future targeted agent in combination therapy in patients with PMBL
    Meeting Abstract

    Lee, S.; Yin, C.; Ayello, J.; Morris, E.; Harrison, L.; van de Ven, C.; Barth, M. J.; Miles, R. R.; Galardy, P. J.; Goldman, S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Ibrutinib significantly prolonged survival in a human Burkitt lymphoma (BL) xenograft NSG mouse model: Ibrutinib may be a potential adjuvant agent in the treatment of BL
    Meeting Abstract

    Lee, S.; Yin, C.; Ayello, J.; Morris, E.; O'Connell, T.; Harrison, L.; van de Ven, C.; Barth, M. J.; Miles, R. R.; Galardy, P. J.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Incidence and management of proteasome inhibitor-related cardiotoxicity in multiple myeloma patients at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Land, J.; Afifi, S.; Adel, N. G.; Devlin, S.; Arora, A.; Lendvai, N.; Landgren, O.
    Blood (2015)

    Fulltext@MSK | Save